276 related articles for article (PubMed ID: 34493831)
1. Induction of dopaminergic neurons for neuronal subtype-specific modeling of psychiatric disease risk.
Powell SK; O'Shea C; Townsley K; Prytkova I; Dobrindt K; Elahi R; Iskhakova M; Lambert T; Valada A; Liao W; Ho SM; Slesinger PA; Huckins LM; Akbarian S; Brennand KJ
Mol Psychiatry; 2023 May; 28(5):1970-1982. PubMed ID: 34493831
[TBL] [Abstract][Full Text] [Related]
2. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.
Sagal J; Zhan X; Xu J; Tilghman J; Karuppagounder SS; Chen L; Dawson VL; Dawson TM; Laterra J; Ying M
Stem Cells Transl Med; 2014 Aug; 3(8):888-98. PubMed ID: 24904172
[TBL] [Abstract][Full Text] [Related]
3. Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells.
Kato T; Nishimura K; Hirao M; Shimohama S; Takata K
Neuropsychopharmacol Rep; 2023 Sep; 43(3):440-445. PubMed ID: 37366076
[TBL] [Abstract][Full Text] [Related]
4. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.
Sánchez-Danés A; Consiglio A; Richaud Y; Rodríguez-Pizà I; Dehay B; Edel M; Bové J; Memo M; Vila M; Raya A; Izpisua Belmonte JC
Hum Gene Ther; 2012 Jan; 23(1):56-69. PubMed ID: 21877920
[TBL] [Abstract][Full Text] [Related]
5. Physiological characterisation of human iPS-derived dopaminergic neurons.
Hartfield EM; Yamasaki-Mann M; Ribeiro Fernandes HJ; Vowles J; James WS; Cowley SA; Wade-Martins R
PLoS One; 2014; 9(2):e87388. PubMed ID: 24586273
[TBL] [Abstract][Full Text] [Related]
6. Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
Bono F; Savoia P; Guglielmi A; Gennarelli M; Piovani G; Sigala S; Leo D; Espinoza S; Gainetdinov RR; Devoto P; Spano P; Missale C; Fiorentini C
Mol Neurobiol; 2018 Feb; 55(2):1054-1067. PubMed ID: 28092083
[TBL] [Abstract][Full Text] [Related]
7. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.
Xue Y; Zhan X; Sun S; Karuppagounder SS; Xia S; Dawson VL; Dawson TM; Laterra J; Zhang J; Ying M
Stem Cells Transl Med; 2019 Feb; 8(2):112-123. PubMed ID: 30387318
[TBL] [Abstract][Full Text] [Related]
8. A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons.
Stathakos P; Jiménez-Moreno N; Crompton LA; Nistor PA; Badger JL; Barbuti PA; Kerrigan TL; Randall AD; Caldwell MA; Lane JD
Autophagy; 2021 Apr; 17(4):855-871. PubMed ID: 32286126
[TBL] [Abstract][Full Text] [Related]
9. Homogenous generation of dopaminergic neurons from multiple hiPSC lines by transient expression of transcription factors.
Mahajani S; Raina A; Fokken C; Kügler S; Bähr M
Cell Death Dis; 2019 Nov; 10(12):898. PubMed ID: 31776327
[TBL] [Abstract][Full Text] [Related]
10. Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.
Sheta R; Teixeira M; Idi W; Pierre M; de Rus Jacquet A; Emond V; Zorca CE; Vanderperre B; Durcan TM; Fon EA; Calon F; Chahine M; Oueslati A
Sci Rep; 2022 Oct; 12(1):17176. PubMed ID: 36229560
[TBL] [Abstract][Full Text] [Related]
11. Dopamine Induces Oscillatory Activities in Human Midbrain Neurons with Parkin Mutations.
Zhong P; Hu Z; Jiang H; Yan Z; Feng J
Cell Rep; 2017 May; 19(5):1033-1044. PubMed ID: 28467897
[TBL] [Abstract][Full Text] [Related]
12. Development and Dynamic Regulation of Mitochondrial Network in Human Midbrain Dopaminergic Neurons Differentiated from iPSCs.
Fang D; Qing Y; Yan S; Chen D; Yan SS
Stem Cell Reports; 2016 Oct; 7(4):678-692. PubMed ID: 27666790
[TBL] [Abstract][Full Text] [Related]
13. Rapid Conversion of Human Induced Pluripotent Stem Cells into Dopaminergic Neurons by Inducible Expression of Two Transcription Factors.
Nishimura K; Nitta T; Doi K; Takata K
Stem Cells Dev; 2022 Jun; 31(11-12):269-277. PubMed ID: 35420042
[TBL] [Abstract][Full Text] [Related]
14. Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.
Salti A; Nat R; Neto S; Puschban Z; Wenning G; Dechant G
Stem Cells Dev; 2013 Feb; 22(3):397-411. PubMed ID: 22889265
[TBL] [Abstract][Full Text] [Related]
15. Role of Chromatin Remodeling Genes and TETs in the Development of Human Midbrain Dopaminergic Neurons.
Xiang L; Huang G; Shu W; Gong C; Cao N; Chen R; Li J; Lu H; Jiang G
Stem Cell Rev Rep; 2020 Aug; 16(4):718-729. PubMed ID: 32367481
[TBL] [Abstract][Full Text] [Related]
16. Generation of Cortical, Dopaminergic, Motor, and Sensory Neurons from Human Pluripotent Stem Cells.
Tay SH; Winanto ; Khong ZJ; Koh YH; Ng SY
Methods Mol Biol; 2022; 2549():359-377. PubMed ID: 33959917
[TBL] [Abstract][Full Text] [Related]
17. Genetic control of midbrain dopaminergic neuron development.
Blaess S; Ang SL
Wiley Interdiscip Rev Dev Biol; 2015; 4(2):113-34. PubMed ID: 25565353
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional comparison of human induced and primary midbrain dopaminergic neurons.
Xia N; Zhang P; Fang F; Wang Z; Rothstein M; Angulo B; Chiang R; Taylor J; Reijo Pera RA
Sci Rep; 2016 Feb; 6():20270. PubMed ID: 26842779
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine Affects Differentiation of Midbrain Dopaminergic Neurons In Vitro.
Lupu D; Varshney MK; Mucs D; Inzunza J; Norinder U; Loghin F; Nalvarte I; Rüegg J
Mol Pharmacol; 2018 Oct; 94(4):1220-1231. PubMed ID: 30115672
[TBL] [Abstract][Full Text] [Related]
20. Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN-4 downregulation.
Corti S; Bonjean R; Legier T; Rattier D; Melon C; Salin P; Toso EA; Kyba M; Kerkerian-Le Goff L; Maina F; Dono R
Stem Cells Transl Med; 2021 May; 10(5):725-742. PubMed ID: 33528918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
